Evaxion A/S (EVAX) Discusses EVX-01 Phase II Clinical and Immune Data in Advanced Melanoma - Slideshow

What happened: Evaxion A/S published a slide deck in conjunction with an event discussing EVX-01 Phase II clinical and immune data in advanced melanoma. Why it matters: The slide deck accompanies the company's presentation of Phase II clinical and immune data for EVX-01 in advanced melanoma.

Evaxion A/S published a slide deck in conjunction with an event discussing EVX-01 Phase II clinical and immune data in advanced melanoma.

The slide deck accompanies the company's presentation of Phase II clinical and immune data for EVX-01 in advanced melanoma.